DEF 14A

Company

Cue Biopharma, Inc.

Filed

June 18, 2019

Period of Report

August 6, 2019

Accession Number

0001193125-19-175745

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →